| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
FORT LAUDERDALE, Fla.—A global provider of drug development and commercialization solutions and services has signed a new agreement extending its relationship with OmniComm Systems Inc., a provider of clinical data management technology, for another seven years. Under the terms of the agreement, the contract research organization (CRO) will use OmniComm’s TrialOne eClinical solution to automate early-phase studies at one of its U.S.-based clinical research units.
 
The CRO selected TrialOne, apart from its status as the market-leading eSource and site automation system for Phase 1 clinics, because TrialOne enables research organizations to greatly improve the productivity and efficiency of their Phase 1 clinics.
 
Browser-based, tablet-compatible TrialOne streamlines and automates key processes for early-phase clinics, which drive efficiencies and reduce timelines and costs through faster and more directed volunteer recruitment, easy-to-build schedule-based workflows, real-time bedside data collection, direct data capture from devices, sample processing automation and data processing. The automation reduces workload on clinic staff and improves the clinical trial experience for volunteers.
 
“Each new contract documents TrialOne’s position as the market-leading eSource solution for Phase 1 clinics,” said Dr. Kuno van der Post, OmniComm’s chief commercial officer. “We’re excited to continue building our partnership with this leading CRO.”

Related Topics

Published In

Volume 14 - Issue 11 | November 2018

November 2018

November 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist using a digital tablet with futuristic data visualization graphics overlaying the screen, representing advanced laboratory data management and analysis

Unlocking laboratory efficiency: a complete guide to LIMS selection

Discover how to choose, implement, and optimize laboratory information management systems (LIMS) to streamline lab operations and ensure compliance.
Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue